Delek US Holdings, Inc. (NYSE:DK - Get Free Report) has been given a consensus recommendation of "Reduce" by the twelve brokerages that are covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $17.27.
A number of equities analysts have weighed in on the company. Piper Sandler reduced their price target on Delek US from $18.00 to $17.00 and set a "neutral" rating for the company in a research report on Friday, March 7th. Scotiabank reduced their price target on Delek US from $24.00 to $14.00 and set a "sector perform" rating for the company in a research report on Friday, April 11th. Raymond James reduced their price target on Delek US from $24.00 to $23.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Mizuho raised Delek US from a "neutral" rating to an "outperform" rating and increased their price objective for the company from $22.00 to $23.00 in a report on Tuesday, May 13th. Finally, The Goldman Sachs Group increased their price objective on Delek US from $15.00 to $17.00 and gave the company a "neutral" rating in a report on Friday, May 23rd.
View Our Latest Stock Analysis on Delek US
Insider Buying and Selling at Delek US
In related news, CFO Mark Wayne Hobbs acquired 2,800 shares of the firm's stock in a transaction on Tuesday, March 11th. The shares were purchased at an average cost of $13.70 per share, for a total transaction of $38,360.00. Following the completion of the acquisition, the chief financial officer now directly owns 49,138 shares in the company, valued at approximately $673,190.60. This trade represents a 6.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have purchased a total of 5,055 shares of company stock worth $70,787 over the last ninety days. Insiders own 1.80% of the company's stock.
Hedge Funds Weigh In On Delek US
Institutional investors and hedge funds have recently modified their holdings of the stock. Ion Asset Management Ltd. lifted its holdings in shares of Delek US by 6.4% during the first quarter. Ion Asset Management Ltd. now owns 3,676,400 shares of the oil and gas company's stock worth $55,403,000 after buying an additional 221,400 shares in the last quarter. Barclays PLC lifted its holdings in shares of Delek US by 23.1% during the fourth quarter. Barclays PLC now owns 1,842,035 shares of the oil and gas company's stock worth $34,078,000 after buying an additional 345,210 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Delek US by 35.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,037,599 shares of the oil and gas company's stock worth $15,637,000 after buying an additional 270,792 shares in the last quarter. Nuveen Asset Management LLC lifted its holdings in shares of Delek US by 21.9% during the fourth quarter. Nuveen Asset Management LLC now owns 1,005,309 shares of the oil and gas company's stock worth $18,598,000 after buying an additional 180,498 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in shares of Delek US by 9.2% during the first quarter. Northern Trust Corp now owns 987,086 shares of the oil and gas company's stock worth $14,875,000 after buying an additional 83,246 shares in the last quarter. 97.01% of the stock is currently owned by institutional investors and hedge funds.
Delek US Stock Up 2.6%
Shares of DK traded up $0.48 on Thursday, hitting $19.10. The company's stock had a trading volume of 1,033,113 shares, compared to its average volume of 1,309,044. The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 3.18. The firm's fifty day moving average price is $15.25 and its 200-day moving average price is $16.81. Delek US has a fifty-two week low of $11.03 and a fifty-two week high of $25.68. The firm has a market capitalization of $1.16 billion, a price-to-earnings ratio of -3.93 and a beta of 0.74.
Delek US (NYSE:DK - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The oil and gas company reported ($2.32) earnings per share for the quarter, missing analysts' consensus estimates of ($2.27) by ($0.05). Delek US had a negative return on equity of 28.21% and a negative net margin of 2.27%. The firm had revenue of $2.64 billion for the quarter, compared to analyst estimates of $2.56 billion. During the same period last year, the company earned ($0.41) EPS. The company's revenue was down 18.1% compared to the same quarter last year. On average, equities research analysts expect that Delek US will post -5.5 EPS for the current year.
Delek US Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, May 19th. Shareholders of record on Monday, May 12th were issued a $0.255 dividend. The ex-dividend date of this dividend was Monday, May 12th. This represents a $1.02 annualized dividend and a dividend yield of 5.34%. Delek US's dividend payout ratio is currently -9.18%.
Delek US Company Profile
(
Get Free ReportDelek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Recommended Stories

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.